ONYX PHARMACEUTICALS INC Stock-Based Compensation
ONYX PHARMACEUTICALS INC reported Stock-Based Compensation of $21.85 million for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2013-08-09
- ONYX PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2013-06-30 was $13.01M, a 14.93% increase year-over-year.
- ONYX PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2013-03-31 was $8.85M, a 21.92% increase year-over-year.
- ONYX PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2012-12-31 was $10.38M, a 150.42% increase year-over-year.
- ONYX PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2012-09-30 was $9.39M, a 6.90% increase year-over-year.
- ONYX PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2012 was $38.34M, a 41.58% increase from fiscal 2011.
- ONYX PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2011 was $27.08M, a 18.79% increase from fiscal 2010.
- ONYX PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2010 was $22.80M, a 1.05% increase from fiscal 2009.
- ONYX PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2009 was $22.56M, a 10.02% increase from fiscal 2008.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2013-06-30 | $13.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $21.85M 10-Q · filed 2013-08-09 | $32.23M derived: sum of 3 quarters · filed 2013-08-09 | $41.62M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | $8.85M 10-Q · filed 2013-05-08 | $19.22M derived: sum of 2 quarters · filed 2013-05-08 | $28.61M derived: sum of 3 quarters · filed 2013-05-08 | $39.93M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | $10.38M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $19.77M derived: sum of 2 quarters · filed 2013-02-28 | $31.08M derived: sum of 3 quarters · filed 2013-08-09 | $38.34M 10-K · filed 2013-02-28 |
| 2012-09-30 | $9.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $20.71M derived: sum of 2 quarters · filed 2013-08-09 | $27.96M 10-Q · filed 2012-11-02 | $32.11M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | $11.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $18.57M 10-Q · filed 2013-08-09 | $22.72M derived: sum of 3 quarters · filed 2013-08-09 | $31.50M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | $7.26M 10-Q · filed 2013-05-08 | $11.40M derived: sum of 2 quarters · filed 2013-05-08 | $20.19M derived: sum of 3 quarters · filed 2013-05-08 | $28.59M derived: sum of 4 quarters · filed 2013-05-08 |
| 2011-12-31 | $4.14M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $12.93M derived: sum of 2 quarters · filed 2013-02-28 | $21.33M derived: sum of 3 quarters · filed 2013-02-28 | $27.08M 10-K · filed 2013-02-28 |
| 2011-09-30 | $8.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $17.19M derived: sum of 2 quarters · filed 2012-11-02 | $22.94M 10-Q · filed 2012-11-02 | $28.82M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $8.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06 | $14.15M 10-Q · filed 2012-08-06 | $20.03M derived: sum of 3 quarters · filed 2013-02-28 | $26.00M derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | $5.75M 10-Q · filed 2012-05-04 | $11.63M derived: sum of 2 quarters · filed 2013-02-28 | $17.60M derived: sum of 3 quarters · filed 2013-02-28 | $23.43M derived: sum of 4 quarters · filed 2013-02-28 |
| 2010-12-31 | $5.88M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $11.85M derived: sum of 2 quarters · filed 2013-02-28 | $17.68M derived: sum of 3 quarters · filed 2013-02-28 | $22.80M 10-K · filed 2013-02-28 |
| 2010-09-30 | $5.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $11.79M derived: sum of 2 quarters · filed 2011-11-03 | $16.91M 10-Q · filed 2011-11-03 | $23.27M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-06-30 | $5.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $10.95M 10-Q · filed 2011-08-09 | $17.30M derived: sum of 3 quarters · filed 2012-02-27 | $22.72M derived: sum of 4 quarters · filed 2012-02-27 |
| 2010-03-31 | $5.12M 10-Q · filed 2011-05-10 | $11.48M derived: sum of 2 quarters · filed 2012-02-27 | $16.89M derived: sum of 3 quarters · filed 2012-02-27 | |
| 2009-12-31 | $6.36M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $11.77M derived: sum of 2 quarters · filed 2012-02-27 | $22.56M 10-K · filed 2012-02-27 | |
| 2009-09-30 | $5.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-03 | $16.21M 10-Q · filed 2010-11-03 | ||
| 2009-06-30 | $10.79M 10-Q · filed 2010-08-04 | |||
| 2008-12-31 | $20.51M 10-K · filed 2011-02-23 |